SCHEMBL21779873

SCHEMBL21779873

NC(O)C12CC(C1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18028660 0.77 SLC22A2 (0.40)
SCHEMBL31345052 0.69
SCHEMBL25237741 0.69
SCHEMBL25661411 0.67 GRM1 (0.52)
Hydrochloric Acid SCHEMBL25211924 0.67 MEN1 (0.36)
Hydrochloric Acid SCHEMBL18631597 0.66 GRM1 (0.50)
SCHEMBL20042203 0.65 SMN1; SMN2 (0.42)
SCHEMBL20042205 0.65 SMN1; SMN2 (0.42)
SCHEMBL20042211 0.65 SMN1; SMN2 (0.42)
SCHEMBL11634453 0.64 SLC22A2 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3616753-A1 COMPOUNDS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR Corvus Pharmaceuticals, Inc. (US) 2020-03-04 EP disclosed